Related Experiment Videos
Abnormalities in the composition of serum high density lipoprotein in renal transplant recipients
Insights
Renal transplant recipients show normal HDL-cholesterol but altered HDL composition, with increased apolipoprotein A and HDL-triglyceride. These changes in high-density lipoprotein (HDL) composition may contribute to cardiovascular disease risk.
Area of Science:
- Nephrology
- Cardiology
- Lipid Metabolism
Background:
- Renal transplant recipients have a high incidence of cardiovascular disease.
- Understanding lipid metabolism abnormalities is crucial for managing post-transplant complications.
Purpose of the Study:
- To investigate the levels and composition of high-density lipoprotein (HDL) in renal transplant recipients.
- To determine if alterations in HDL components correlate with increased cardiovascular risk.
Main Methods:
- Serum samples from 26 female and 44 male renal transplant recipients were analyzed.
- Levels of HDL-cholesterol, HDL-triglyceride, and apolipoprotein A were quantified.
- Comparisons were made with control groups.
Main Results:
- No significant differences in HDL-cholesterol levels were observed compared to controls.
- Significantly increased concentrations of apolipoprotein A and HDL-triglyceride were found.
- Abnormal HDL composition was indicated by altered apolipoprotein A/HDL-cholesterol and HDL-cholesterol/HDL-triglyceride ratios.
Conclusions:
- Renal transplant recipients exhibit altered HDL composition despite normal HDL-cholesterol levels.
- Changes in HDL composition, particularly increased apolipoprotein A and HDL-triglyceride, are significant.
- These HDL abnormalities are potential contributors to the high cardiovascular disease incidence in this patient group.
Abstract:
Levels of HDL-cholesterol, HDL-triglyceride and apolipoprotein A were determined in the sera of 26 female and 44 male renal transplant recipients. In comparison with controls, no significant abnormalities in HDL-cholesterol values could be found, but apolipoprotein A and HDL-triglyceride concentrations, were increased significantly. The increased apolipoprotein A/HDL-cholesterol ratio and the decreased apolipoprotein A/HDL-triglyceride and HDL-cholesterol/HDL-triglyceride ratios in these patients demonstrate abnormalities in HDL-composition. These results permit the conclusion that, in renal transplant recipients, the levels of HDL-cholesterol and particularly the changes in HDL-composition should be taken into account when considering the reason for the high incidence of cardiovascular disease in these patients.